Journal of Biological Chemistry · 2008 · 86 citations · 19 references
Life SciencesMolecular BiologyOncologyChromatin StructureDna RepairTranscriptional RegulationCancer EpigeneticsChromatinEpigenetic Regulation In CancerHistone ModificationsHistone ProteinsPromoter RegulationChromatin FunctionChromatin-mediated Gene RegulationCircadian Promoter ElementsCircadian Transcriptional RegulationClock Gene Promoter ElementsClock Gene Transcriptional RegulationHistone AcetylationHistone Acetyltransferases
Histone modification is important for maintaining chromatin structure and function. Recently, histone acetylation has been shown to have a critical regulatory role in both transcription and DNA repair. We report here that expression of histone acetyltransferase (HAT) genes is associated with cisplatin resistance. We found that Tip60 is overexpressed in cisplatin-resistant cells. The expression of two other HAT genes, HAT1 and MYST1, did not differ between drug-sensitive and -resistant cells. Knockdown of Tip60 expression rendered cells sensitive to cisplatin but not to oxaliplatin, vincristine, and etoposide. Tip60 expression is significantly correlated with cisplatin sensitivity in human lung cancer cell lines. Interestingly, the promoter region of the Tip60 gene contains several E boxes, and its expression was regulated by the E-box binding circadian transcription factor Clock but not by other E-box binding transcription factors such as c-Myc, Twist, and USF1. Hyperacetylation of H3K14 and H4K16 was found in cisplatin-resistant cells. The microarray study reveals that several genes for DNA repair are down-regulated by the knockdown of Tip60 expression. Our data show that HAT gene expression is required for cisplatin resistance and suggest that Clock and Tip60 regulate not only transcription, but also DNA repair, through periodic histone acetylation. Histone modification is important for maintaining chromatin structure and function. Recently, histone acetylation has been shown to have a critical regulatory role in both transcription and DNA repair. We report here that expression of histone acetyltransferase (HAT) genes is associated with cisplatin resistance. We found that Tip60 is overexpressed in cisplatin-resistant cells. The expression of two other HAT genes, HAT1 and MYST1, did not differ between drug-sensitive and -resistant cells. Knockdown of Tip60 expression rendered cells sensitive to cisplatin but not to oxaliplatin, vincristine, and etoposide. Tip60 expression is significantly correlated with cisplatin sensitivity in human lung cancer cell lines. Interestingly, the promoter region of the Tip60 gene contains several E boxes, and its expression was regulated by the E-box binding circadian transcription factor Clock but not by other E-box binding transcription factors such as c-Myc, Twist, and USF1. Hyperacetylation of H3K14 and H4K16 was found in cisplatin-resistant cells. The microarray study reveals that several genes for DNA repair are down-regulated by the knockdown of Tip60 expression. Our data show that HAT gene expression is required for cisplatin resistance and suggest that Clock and Tip60 regulate not only transcription, but also DNA repair, through periodic histone acetylation. Our research has focused on factors affecting cellular sensitivity of solid tumors to anticancer agents and investigation of promising molecular targets for cancer treatment (1Kohno K. Uchiumi T. Niina I. Wakasugi T. Igarashi T. Momii Y. Yoshida T. Matsuo K. Miyamoto N. Izumi H. Eur. J. Cancer. 2005; 41: 2577-2586Abstract Full Text Full Text PDF PubMed Scopus (70) Google Scholar, 2Torigoe T. Izumi H. Ishiguchi H. Yoshida Y. Tanabe M. Yoshida T. Igarashi T. Niina I. Wakasugi T. Imaizumi T. Momii Y. Kuwano M. Kohno K. Curr. Med. Chem. Anti-Canc. Agents. 2005; 5: 15-27Crossref PubMed Scopus (105) Google Scholar). Among many drugs, cis-diamminechloroplatinum (II) (cisplatin) plays a crucial role in the treatment of various solid tumors (3Zamble D.B. Lippard S.J. Trends Biochem. Sci. 1995; 20: 435-439Abstract Full Text PDF PubMed Scopus (483) Google Scholar, 4Cohen S.M. Lippard S.J. Prog. Nucleic Acids Res. Mol. Biol. 2001; 67: 93-130Crossref PubMed Scopus (555) Google Scholar). Cisplatin has been shown to form a cross-link between adjacent purines in genomic DNA and can cause DNA-damaging signals to induce apoptosis (1Kohno K. Uchiumi T. Niina I. Wakasugi T. Igarashi T. Momii Y. Yoshida T. Matsuo K. Miyamoto N. Izumi H. Eur. J. Cancer. 2005; 41: 2577-2586Abstract Full Text Full Text PDF PubMed Scopus (70) Google Scholar, 2Torigoe T. Izumi H. Ishiguchi H. Yoshida Y. Tanabe M. Yoshida T. Igarashi T. Niina I. Wakasugi T. Imaizumi T. Momii Y. Kuwano M. Kohno K. Curr. Med. Chem. Anti-Canc. Agents. 2005; 5: 15-27Crossref PubMed Scopus (105) Google Scholar). Cisplatin treatment also induces oxidative and endoplasmic reticulum stresses (5Wada T. Penninger J.M. Oncogene. 2004; 23: 2838-2849Crossref PubMed Scopus (1248) Google Scholar). Thus, the nature of cellular sensitivity to cisplatin is highly complex. The development of cisplatin resistance is a major clinical limitation in cancer chemotherapy. Cisplatin resistance is influenced by many factors which affect intracellular drug accumulation (6Fujii R. Mutou M. Niwa K. Yamada K. Akitou T. Nakagawa M. Kuwano M. Akiyama S. Jpn. J. Cancer Res. 1994; 85: 426-433Crossref PubMed Scopus (86) Google Scholar, 7Komatsu M. Sumizawa T. Mutou M. Chen Z.S. Terada K. Furukawa T. Yang X.L. Gao H. Miura N. Sugiyama T. Akiyama S. Cancer Res. 2000; 60: 1312-1316PubMed Google Scholar, 8Nakayama K. Kanzaki A. Ogawa K. Miyazaki K. Neamati N. Takebayashi Y. Int. J. Cancer. 2002; 101: 488-495Crossref PubMed Scopus (128) Google Scholar), increased activity of intracellular thiol production (9Lai G.M. Ozols R.F. Young R.C. Hamilton T.C. J. Natl. Cancer Inst. 1989; 81: 535-539Crossref PubMed Scopus (165) Google Scholar, 10Tew K.D. Cancer Res. 1994; 54: 4313-4320PubMed Google Scholar), and DNA repair (11Chaney S.G. Sancar A. J. Natl. Cancer Inst. 1996; 88: 1346-1360Crossref PubMed Scopus (251) Google Scholar, 12Husain A. He G. Venkatraman E.S. Spriggs D.R. Cancer Res. 1998; 58: 1120-1123PubMed Google Scholar). However, little is known about the molecular mechanisms involved in drug resistance. Cellular factors involved in transcription contribute to the induction of apoptosis or transient or acquired resistance. We have tried to identify the cisplatin-inducible transcription factors and transcription-related factors that are highly expressed in drug-resistant cells (1Kohno K. Uchiumi T. Niina I. Wakasugi T. Igarashi T. Momii Y. Yoshida T. Matsuo K. Miyamoto N. Izumi H. Eur. J. Cancer. 2005; 41: 2577-2586Abstract Full Text Full Text PDF PubMed Scopus (70) Google Scholar, 2Torigoe T. Izumi H. Ishiguchi H. Yoshida Y. Tanabe M. Yoshida T. Igarashi T. Niina I. Wakasugi T. Imaizumi T. Momii Y. Kuwano M. Kohno K. Curr. Med. Chem. Anti-Canc. Agents. 2005; 5: 15-27Crossref PubMed Scopus (105) Google Scholar, 13Murakami T. Shibuya I. Ise T. Chen Z.S. Akiyama S. Nakagawa M. Izumi H. Nakamura T. Matsuo K. Yamada Y. Kohno K. Int. J. Cancer. 2001; 93: 869-874Crossref PubMed Scopus (127) Google Scholar). We have previously shown that expression of activating transcription factor 4 (ATF4) 2The abbreviations used are: ATF4, transcription factor 4; Tip60, human immunodeficiency virus-1-tat interactive protein; HAT, histone acetyltransferase; ERCC1, excision repair cross-complementation group 1; APE1, apurinic/apyrimidinic exonuclease 1; Clock, circadian locomotor output cycles kaput; Bmal1, brain and muscle ARNT-like protein 1; USF1, upstream stimulatory factor 1; MYST1, MYST histone acetyltransferase 1; siRNA, small interference RNA; PCNA, proliferating cell nuclear antigen; ChIP, chromatin immunoprecipitation; HA, hemagglutinin. is inducible by cisplatin treatment and is high in cisplatin-resistant cells (14Tanabe M. Izumi H. Ise T. Chen S.J. Higuchi S. Yamori T. Yasumoto K. Kohno K. Cancer Res. 2003; 63: 8592-8595PubMed Google Scholar). The cellular level of ATF4 expression correlates with cisplatin sensitivity in human lung cancer cell lines. DNA microarray analysis has revealed that ATF4 regulates genes involved in glutathione biosynthesis and conjugation (15Harding H.P. Zhang Y. Zeng H. Novoa I. Lu P.D. Calfon M. Sadri N. Yun C. Popko B. Stojdl D.F. Bell J.C. Hettmann T. Leiden J.M. Ron D. Mol. Cell. 2003; 11: 619-633Abstract Full Text Full Text PDF PubMed Scopus (2410) Google Scholar). Interestingly, we have found that ATF4 gene expression is regulated by the circadian transcription factor Clock, which is also overexpressed in cisplatin-resistant cells (16Igarashi T. Izumi H. Uchiumi T. Nishio K. Arao T. Tanabe M. Uramoto H. Sugio K. Yasumoto K. Sasaguri Y. Wang K.W. Otsuji Y. Kohno K. Oncogene. 2007; 26: 4749-4760Crossref PubMed Scopus (117) Google Scholar). It has recently been shown that histones are periodically acetylated (17Etchegaray J.P. Lee C. Wada P.A. Reppert S.M. Nature. 2003; 421: 177-182Crossref PubMed Scopus (546) Google Scholar) and that Clock is a member of the histone acetyltransferases (18Doi M. Hirayama J. Sassone-Corsi P. Cell. 2006; 125: 497-508Abstract Full Text Full Text PDF PubMed Scopus (665) Google Scholar). Clock seems to have a highly specific enzymatic activity and acetylates histone 3 and histone 4 (19Nakahata Y. Grimaldi B. Sahar S. Hirayama J. Sassone-Corsi P. Curr. Opin. Cell Biol. 2007; 19: 230-237Crossref PubMed Scopus (75) Google Scholar). Acetylation of histone 4 has been shown to be required for repair of DNA double-strand breaks. The yeast human histone acetyltransferases (HAT) Esa1 mutant is defective for NHEJ (non-homologous end joining) and is markedly hypersensitive to DNA-damaging agents, such as camptothecin-11 and methyl methanesulfonate (20Bird A.W. Yu D.Y. Pray-Grant M.G. Qiu Q. Harmon K.E. Megee P.C. Grant P.A. Smith M.M. Christman M.F. Nature. 2002; 419: 411-415Crossref PubMed Scopus (468) Google Scholar). The acetyl-CoA binding motif is found in Clock and shows high sequence similarity to yeast Esa1 and other MYST members. One of the MYST family members, Tip60, has been shown to be involved in DNA repair and apoptosis (21Ikura T. Ogryzko V.V. Grigoriev M. Groisman R. Wang J. Horikoshi M. Scully R. Qin J. Nakatani Y. Cell. 2000; 102: 463-473Abstract Full Text Full Text PDF PubMed Scopus (876) Google Scholar). Through our studies seeking to determine the role of HAT in cisplatin resistance, we found that Tip60, but not HAT1 and MYST1, was overexpressed in cisplatin-resistant cells. Silencing of Tip60 expression effectively sensitized both parental and resistant cells to cisplatin, but not to oxaliplatin, vincristine, and etoposide. These results can open new aspects of cisplatin resistance. Cell Culture—Human epidermoid cancer KB cells and human prostate cancer PC3 cells were cultured in Eagle's minimal essential medium. This medium was purchased from Nissui Seiyaku (Tokyo, Japan) and contained 10% fetal bovine serum. The cisplatin-resistant KB/CP4 and P/CDP6 cells were derived from KB and PC3 cells as described previously (13Murakami T. Shibuya I. Ise T. Chen Z.S. Akiyama S. Nakagawa M. Izumi H. Nakamura T. Matsuo K. Yamada Y. Kohno K. Int. J. Cancer. 2001; 93: 869-874Crossref PubMed Scopus (127) Google Scholar) and were found to be 23–63-fold more resistant to cisplatin than their parental cells (6Fujii R. Mutou M. Niwa K. Yamada K. Akitou T. Nakagawa M. Kuwano M. Akiyama S. Jpn. J. Cancer Res. 1994; 85: 426-433Crossref PubMed Scopus (86) Google Scholar). Eleven lung cancer cell lines were cultured as described previously (14Tanabe M. Izumi H. Ise T. Chen S.J. Higuchi S. Yamori T. Yasumoto K. Kohno K. Cancer Res. 2003; 63: 8592-8595PubMed Google Scholar). Cell lines were maintained in a 5% CO2 atmosphere and Clock Tip60 HAT1 H4K16 and were purchased from and were purchased from and was purchased from Cell was purchased from vincristine, and were purchased from was from (Tokyo, the DNA for human Clock and human Bmal1, was on a the the and for and and for These were the a the was a a Clock, was by of a and a Clock was by of Clock a The promoter and to of the Tip60 gene was by DNA and the and was also to the E-box the Tip60 promoter the and for and and and were and the of the of and have been described previously (16Igarashi T. Izumi H. Uchiumi T. Nishio K. Arao T. Tanabe M. Uramoto H. Sugio K. Yasumoto K. Sasaguri Y. Wang K.W. Otsuji Y. Kohno K. Oncogene. 2007; 26: 4749-4760Crossref PubMed Scopus (117) Google Scholar, T. Izumi H. Uchiumi T. H. Arao T. Nishio K. Kohno K. Oncogene. 2007; 26: PubMed Scopus Google Scholar). to were for The of or were by or The were to a The were with 5% in and for with a of USF1, c-Myc, and a of MYST1, and H4K16 a of and H3K14 a of and a of and The was with a for and a with was used as and and a were as described previously (16Igarashi T. Izumi H. Uchiumi T. Nishio K. Arao T. Tanabe M. Uramoto H. Sugio K. Yasumoto K. Sasaguri Y. Wang K.W. Otsuji Y. Kohno K. Oncogene. 2007; 26: 4749-4760Crossref PubMed Scopus (117) Google Scholar, T. Izumi H. Uchiumi T. H. Arao T. Nishio K. Kohno K. Oncogene. 2007; 26: PubMed Scopus Google Scholar). The of Tip60 and the expression were to the the cells were cultured for activity was by a and the was with a to the The results shown are to activity and are of Knockdown were Clock small and Tip60 siRNA, and HAT1 siRNA, and siRNA, and siRNA, and siRNA, and siRNA, and were to the with of was in of medium and for or of Clock, Tip60, MYST1, Twist, c-Myc, USF1, and in of were and for and of PC3 cells in of medium were and for of 4 PC3 cells or P/CDP6 cells were used for a as described The cells were in with of medium and for as described was as described previously (16Igarashi T. Izumi H. Uchiumi T. Nishio K. Arao T. Tanabe M. Uramoto H. Sugio K. Yasumoto K. Sasaguri Y. Wang K.W. Otsuji Y. Kohno K. Oncogene. 2007; 26: 4749-4760Crossref PubMed Scopus (117) Google Scholar, T. Izumi H. Uchiumi T. H. Arao T. Nishio K. Kohno K. Oncogene. 2007; 26: PubMed Scopus Google Scholar). chromatin from PC3 or cells was with of and or PC3 cells were with or Clock and cultured for as described chromatin from cells was with of or with protein were and in of of DNA was used for analysis with the Tip60 to and Tip60 to and Tip60 to and Tip60 to and The were by on and with the 4 PC3 cells or P/CDP6 cells with were in with of medium. The the cells were with of cisplatin, oxaliplatin, and the of was we from the was the for from cells and were the on the and by on a and from PC3 cells with or Tip60 were and with to the the and the was a and the were to of the the of and of were and to the as described in the were as described in the and the DNA microarray The were to data with were and The were by the DNA microarray by and by of was used for of protein by were with the The was used for and was the 5% Tip60 in are on the of their Mol. Cell Biol. 2007; PubMed Scopus Google Scholar). The family and The MYST family is for the of HAT and protein and of the nuclear A. K. Horikoshi M. J. Biochem. 2005; PubMed Scopus Google Scholar). We the expression of human HAT genes, Tip60, MYST1, and in and -resistant cells. shown in Tip60 was overexpressed in cisplatin-resistant cells with sensitive cells. the other cellular expression of two HAT genes, and was in drug-sensitive and -resistant cells. we also other and PCNA, was in their expression in drug-sensitive and -resistant cells. Tip60 Silencing to Tip60 is involved in drug resistance, was Cisplatin sensitivity was significantly by the knockdown of Tip60 expression Knockdown of Tip60 expression did not induce cellular sensitivity to vincristine, and We of Tip60 expression cisplatin resistance in cisplatin-resistant cell shown in of Tip60 expression cisplatin resistance. We also that knockdown of other HAT genes, and did not induce cellular sensitivity to cisplatin not Clock Tip60 the Tip60 was overexpressed in cisplatin-resistant we the of the promoter of the Tip60 are two in the promoter region of the Tip60 gene We have previously shown that the E-box binding transcription factor Clock is overexpressed in cisplatin-resistant cells (16Igarashi T. Izumi H. Uchiumi T. Nishio K. Arao T. Tanabe M. Uramoto H. Sugio K. Yasumoto K. Sasaguri Y. Wang K.W. Otsuji Y. Kohno K. Oncogene. 2007; 26: 4749-4760Crossref PubMed Scopus (117) Google Scholar). This to circadian transcription factor Clock is involved in Tip60 gene expression. Knockdown of Clock expression markedly the expression of Tip60 in two human cancer PC3 and KB cell lines the other the expression of other E-box binding c-Myc, Twist, and USF1, did not the expression of Tip60 The transcription factors that to E-box plays role in the transcription of We have the in the two of Tip60 promoter as shown in The that of both Clock and expression level of However, was the was used of Clock expression the promoter activity of the Tip60 gene gene expression is regulated through the in the promoter region by Clock but not by c-Myc, Twist, and USF1. or Clock were PC3 cells and KB cells. of were to and was with the is shown were PC3 cells and KB cells. for and USF1, and for were to and was with the is shown in Histone Acetylation in and -resistant has been shown that Clock is a HAT (18Doi M. Hirayama J. Sassone-Corsi P. Cell. 2006; 125: 497-508Abstract Full Text Full Text PDF PubMed Scopus (665) Google Scholar) and is overexpressed in cisplatin-resistant cells (16Igarashi T. Izumi H. Uchiumi T. Nishio K. Arao T. Tanabe M. Uramoto H. Sugio K. Yasumoto K. Sasaguri Y. Wang K.W. Otsuji Y. Kohno K. Oncogene. 2007; 26: 4749-4760Crossref PubMed Scopus (117) Google Scholar). determine of Clock and Tip60 to histone acetylation in cisplatin-resistant we acetylated Hyperacetylation of histones was in cisplatin-resistant cells H3K14 and H4K16 were significantly in cisplatin-resistant cells in with parental cells. the other the acetylation of both and did not between drug-sensitive and -resistant cells. of both Clock and Tip60 enzymatic activity was by specific for Clock and Knockdown of Clock expression the acetylation of H3K14 and and knockdown of Tip60 expression the acetylation of H4K16 in both and -resistant cells. The acetylation of both and did not in and -resistant cells by specific for Clock or Our results that Clock acetylates H3K14 and Tip60 acetylates H4K16 in drug-sensitive and -resistant cells Clock and Tip60 histone acetylation. PC3 and cells were with Clock and Tip60 for Clock and and for and H3K14 and for and were to and was with the is shown Clock and Histone with the Tip60 determine the of on the Tip60 promoter was a of of to the we of the promoter and end of the Tip60 transient of PC3 cells with a Clock expression was a was with shown in we found that Clock was only in shows that the nuclear Clock with the Tip60 promoter was two and the Tip60 promoter from both PC3 and P/CDP6 cells We have also the of H3K14 and H4K16 acetylation associated with the Tip60 PC3 and P/CDP6 cells were to with acetylated H3K14 and Interestingly, was that acetylated H3K14 was markedly to the Tip60 promoter both Tip60 and were used the other H4K16 acetylation was of the shows that drug resistant P/CDP6 cells have a in Clock and acetylated H3K14 binding to the Tip60 promoter with PC3 cells Cellular of Tip60 with Cisplatin the between Tip60 expression and cisplatin sensitivity in lung cancer cell lines of was also as a expression in cisplatin-resistant cells is to that in parental cells Tip60 expression significantly correlated with cisplatin sensitivity and Clock expression We have previously shown that Clock expression correlated with cisplatin sensitivity (16Igarashi T. Izumi H. Uchiumi T. Nishio K. Arao T. Tanabe M. Uramoto H. Sugio K. Yasumoto K. Sasaguri Y. Wang K.W. Otsuji Y. Kohno K. Oncogene. 2007; 26: 4749-4760Crossref PubMed Scopus (117) Google Scholar). of the the Tip60 genes is we used microarray the by the Tip60 siRNA, DNA microarray study was in PC3 cells with or Tip60 analysis genes, which were down-regulated more than and genes, which were not Among down-regulated genes, several genes involved in DNA repair was It was that was of the to determine the cellular sensitivity of cisplatin A. P. M. R. R. J.P. T. T. J.C. N. J. Med. 2006; PubMed Scopus Google Scholar, T. I. H. T. T. A. Y. Int. J. Cancer. 2007; PubMed Scopus Google Scholar). the microarray we two genes and their expression by and Mol. Cancer Res. 2007; 5: PubMed Scopus Google Scholar) were significantly down-regulated by the Tip60 the expression of genes was significantly in cisplatin-resistant cells of DNA repair genes regulated by Tip60 DNA microarray analysis of genes was microarray study was in PC3 cells with Tip60 or analysis genes, which were down-regulated more than The of DNA repair genes was between Tip60 and of Tip60 with repair DNA repair protein immunodeficiency protein protein repair repair group repair repair group repair repair group in a new in transcription are to a major role in as as in and resistance to anticancer agents (1Kohno K. Uchiumi T. Niina I. Wakasugi T. Igarashi T. Momii Y. Yoshida T. Matsuo K. Miyamoto N. Izumi H. Eur. J. Cancer. 2005; 41: 2577-2586Abstract Full Text Full Text PDF PubMed Scopus (70) Google Scholar, 2Torigoe T. Izumi H. Ishiguchi H. Yoshida Y. Tanabe M. Yoshida T. Igarashi T. Niina I. Wakasugi T. Imaizumi T. Momii Y. Kuwano M. Kohno K. Curr. Med. Chem. Anti-Canc. Agents. 2005; 5: 15-27Crossref PubMed Scopus (105) Google Scholar). Our was to identify transcription-related factors expression was and involved in cisplatin resistance (1Kohno K. Uchiumi T. Niina I. Wakasugi T. Igarashi T. Momii Y. Yoshida T. Matsuo K. Miyamoto N. Izumi H. Eur. J. Cancer. 2005; 41: 2577-2586Abstract Full Text Full Text PDF PubMed Scopus (70) Google Scholar, 2Torigoe T. Izumi H. Ishiguchi H. Yoshida Y. Tanabe M. Yoshida T. Igarashi T. Niina I. Wakasugi T. Imaizumi T. Momii Y. Kuwano M. Kohno K. Curr. Med. Chem. Anti-Canc. Agents. 2005; 5: 15-27Crossref PubMed Scopus (105) Google Scholar, 13Murakami T. Shibuya I. Ise T. Chen Z.S. Akiyama S. Nakagawa M. Izumi H. Nakamura T. Matsuo K. Yamada Y. Kohno K. Int. J. Cancer. 2001; 93: 869-874Crossref PubMed Scopus (127) Google Scholar). Recently, we have that the circadian transcription factor Clock is overexpressed in cisplatin-resistant cells (16Igarashi T. Izumi H. Uchiumi T. Nishio K. Arao T. Tanabe M. Uramoto H. Sugio K. Yasumoto K. Sasaguri Y. Wang K.W. Otsuji Y. Kohno K. Oncogene. 2007; 26: 4749-4760Crossref PubMed Scopus (117) Google Scholar). Clock has recently been found to have HAT activity (18Doi M. Hirayama J. Sassone-Corsi P. Cell. 2006; 125: 497-508Abstract Full Text Full Text PDF PubMed Scopus (665) Google Scholar). The HAT activity is required to Thus, Clock transcription by chromatin and the of to the promoter Tip60 was as a cellular acetyltransferase that with human immunodeficiency protein J. B. T. D. G. 1996; PubMed Scopus Google Scholar). Tip60 as a protein on chromatin and has been shown to be involved in DNA and repair (20Bird A.W. Yu D.Y. Pray-Grant M.G. Qiu Q. Harmon K.E. Megee P.C. Grant P.A. Smith M.M. Christman M.F. Nature. 2002; 419: 411-415Crossref PubMed Scopus (468) Google Scholar, M. C. B. Trends Cell Biol. 2006; Full Text Full Text PDF PubMed Scopus Google Scholar). These to the that HAT gene expression affect cellular sensitivity to DNA-damaging agents the study we which are involved in cellular sensitivity to anticancer agents and drug resistance. We found that Tip60 was overexpressed in cisplatin-resistant but and HAT1 were not We have previously shown that of the cellular expression of the Clock protein cisplatin and sensitivity to human lung cancer cell lines (16Igarashi T. Izumi H. Uchiumi T. Nishio K. Arao T. Tanabe M. Uramoto H. Sugio K. Yasumoto K. Sasaguri Y. Wang K.W. Otsuji Y. Kohno K. Oncogene. 2007; 26: 4749-4760Crossref PubMed Scopus (117) Google Scholar). we also found that Tip60 expression correlated with cisplatin sensitivity However, of Tip60 expression only cisplatin sensitivity which a through which Clock or Tip60 drug mechanisms are involved in the of cisplatin resistance cisplatin increased of cellular and increased DNA repair These that the knockdown of Tip60 expression by Tip60 only a small on the cellular sensitivity of cisplatin and We have previously shown that ATF4 is a of Clock, and the Clock and ATF4 transcription plays important role in resistance through a (16Igarashi T. Izumi H. Uchiumi T. Nishio K. Arao T. Tanabe M. Uramoto H. Sugio K. Yasumoto K. Sasaguri Y. Wang K.W. Otsuji Y. Kohno K. Oncogene. 2007; 26: 4749-4760Crossref PubMed Scopus (117) Google Scholar). The knockdown of Tip60 expression also a on the cellular sensitivity in drug-sensitive DNA microarray analysis several DNA repair genes are regulated by the Tip60 expression shown in both and gene are regulated by the molecular of the expression of Tip60 in cisplatin-resistant we the transcription factor binding in the promoter region the human data are two in the promoter region of the Tip60 gene We found that the Tip60 gene is a of Clock but not of the other E-box binding such as Twist, c-Myc, and The also results Our results that Tip60 also be involved in histone acetylation. Histone acetylation in cisplatin-resistant cells is to be regulated by Clock and We found that both H3K14 and H4K16 were highly acetylated in cisplatin-resistant cells It has been shown that Clock can H3K14 (19Nakahata Y. Grimaldi B. Sahar S. Hirayama J. Sassone-Corsi P. Curr. Opin. Cell Biol. 2007; 19: 230-237Crossref PubMed Scopus (75) Google Scholar) and that Tip60 acetylates and Mol. Cell Biol. 2007; PubMed Scopus Google Scholar, M. C. B. Trends Cell Biol. 2006; Full Text Full Text PDF PubMed Scopus Google Scholar), which that H4K16 be by Our results for Clock and Tip60 are with in studies The acetylation of H3K14 has been shown to be involved in (19Nakahata Y. Grimaldi B. Sahar S. Hirayama J. Sassone-Corsi P. Curr. Opin. Cell Biol. 2007; 19: 230-237Crossref PubMed Scopus (75) Google Scholar). It has been shown that the acetylation of H4K16 contribute to the of chromatin M. H. J.M. 2006; PubMed Scopus Google Scholar). shown in the of high Clock binding and acetylation the Tip60 promoter in drug-resistant a more open of chromatin for on Clock be involved in maintaining chromatin structure through H3K14 and Tip60 be involved in chromatin structure in cisplatin-resistant cells. Thus, our results the role that the HAT of both Clock and Tip60 contribute to drug resistance. we that both Clock and Tip60 are required for cisplatin resistance. Our data also suggest that Tip60 a role in circadian function. Our study to molecular the circadian of genomic anticancer agents and drug sensitivity through histone acetylation. We and for
19
Histone H4-K16 Acetylation Controls Chromatin Structure and Protein Interactions
Michael A. Shogren‐Knaak, Haruhiko Ishii, Jian-Min Sun et al. · Science · 2006 · 1.9K citations
Involvement of the TIP60 Histone Acetylase Complex in DNA Repair and Apoptosis
Tsuyoshi Ikura, Vasily Ogryzko, Mikhaïl Grigoriev et al. · Cell · 2000 · 1K citations · Full text
Circadian Regulator CLOCK Is a Histone Acetyltransferase
Masao Doi, Jun Hirayama, Paolo Sassone‐Corsi · Cell · 2006 · 879 citations · Full text